320 likes | 526 Views
Neonatology: Neonatal Septicemia. Lecture points. Morbidity and mortality The compromised host of the neonates in immunology Pathogens for clinical consideration Clinical manifestation Clinical Management. Incidence. 1% ~ 10%, in live birth 15-20%, in VLBW. ‰. ‰. Incidence.
E N D
Lecture points • Morbidity and mortality • The compromised host of the • neonates in immunology • Pathogens for clinical consideration • Clinical manifestation • Clinical Management
Incidence • 1%~10%, in live birth • 15-20%, in VLBW
‰ ‰ Incidence Comparison: US and developing countries Gross incidence
Neonatal Septicemia Death rate: US
death rate: 9.8%~12% LONS 7.5% Neonatal Septicemia Death rate:developing countries
Immunological features in neonates • Immature development in body defense • Imperfect function • Less experience of exposure to environment and pathogens • Affected by maternal antibodies
Immunological features in Neonates Non-specific Immune: • Poor barriers function • Undeveloped complement activation capacity • Relative fewer neutrophil, Immature Function • Lower ILs, lower level of cytokines
Immunological features in Neonates Specific Immune: • Quantities and quality of Ig G, A, M • T, B cell: quantities, quality and their function
Pathogens • Domestic: • Staphylococcus: most commonly seen • Escherichia coli, etc. • G- bacillus • US: • GBS: the leading pathogen during 1970’s • Escherichia coli: the leading pathogen during 1990’s
Pathogenic Changes EONS: Changes by G+ vs. G- ‰ Early 1990’s Late 1990’s
Relevant factors of pathogenic changes • Change of colonized pathogens in maternal birth canal • GBS Screening • Preventive antibiotic therapy used during pre partum • Ampicilline for the mother with GBS positive : • pre partum and Intro-partum GBS Septicemia • Efficacy:around 70%(vs. control P < 0.0001)
EONS: E. coli Listeria monocytogenes, Pseudomonas Meningococcus Enterococcus and GBS LONS: Coagulase-negative Staphylococcus Haemophilus influenza bacillus Other pathogens Pathogens based on the types in developed country
Pathogens based on the types in developing country • VEONS (within 24 hours after birth) • Klebsiella、E. coli、Enterococcus • EONS (within 24-48 hours after birth) G+ = G- G+:mainly Klebsiella pneumoniae and E. coli G-:Enterococcus commonly seen • LONS (48 hours after birth) • Mainly: G+ Coagulase-negative Staphylococcus • Partly reported:Staphylococcus epidermidis, GBS • and E. coli
Pathogens based on the types in developing country Early onset dominant Related with the maternal and the intro-partum high risk factors
Pathogens isolated in China main isolatesfrom blood culture bsed on the ages: n=671/458/1849 临床儿科杂志:2002-2浙江大学附属儿童医院资料
Pathogens isolated in China Domestic data:main isolates: n=815 中华儿科杂志01-6;重庆儿科医院资料
main isolates account for during different periods: n=436 Pathogens isolated in China 临床儿科杂志02-5:深圳市人民医院儿科资料
Pathogens isolated in China main isolates account for during different periods: n=436 临床儿科杂志02-5:深圳市人民医院儿科资料
Pathogens isolated in China main isolates account for during different periods: n=606/475 临床儿科杂志:2002-2 哈尔滨儿童医院资料
The path of Infection • Path: • Intrauterine infection • Intro-partum infection • Post delivering infection
Risk factors of sepsis occurrence • Maternal intro-partum fever (OR=4.1 CI=1.2-13.4) • Repeated Vaginal examinations (OR=2.9 CI=1.1-8.0) • Among GBS Sepsis,Dystocia and maternal fever account for 49% • Prolonged membrane rupture ≥18 hour(79%) • Prematures and LBW • Later onset sepsis: PDA, Long time of Intravascular catheter, various of invasive procedure, BPD
General: Anorexia Less Crying Fewer physical activities Lower temperature or fever Poor weighting gain Persistent Jaundice Focal: Omphalitis Skin infection Blepharitis (eyes) Otitis media Paronychia (nails) Clinical manifestations
Toxic: Shock Hepatosplenomegaly Skin deposition point Distension Anemia Complication: Meningitis Pneumonia Peritonitis Urinary Tract Infection Scleredema DIC Toxic myocarditis Clinical manifestations
Laboratories and investigation aids • Peripheral whole blood test • Blood culture • Others: • CRP/ PCT • Smear of WBC: check bacterial • CSF • Urine • CXR
ClinicalManagement Antibiotic therapy • Selection based on the pathogen isolated • Early,Adequate dose, IV • Duration: • 2 weeks for G+, 3 weeks for G-. • Longer duration for meningitis and severe
Clinical Management Supportive therapy • Dehydration • Correct metabolic acidosis • Maintenance of electrolyte and Acid-base balance • Enough energy supply • Keep warm • Correct hypoxemia • Immunological therapy: IVIG
Clinical Management Complication treatment • Shock • DIC • Scleredema • Respiratory failure • Conversion • Jaundice • Focal lesion
Thanks for listening Questions please?